SNDX
Syndax Pharmaceuticals, Inc. · Healthcare
CEO Michael A Metzger sold $318K of Syndax Pharmaceuticals, Inc.
Sold$318,407
$21.07Price
15,109Shares
−46%Stake
What SNDX did after the filing
- The stock from Fri, Jul 8 close, $19.43
- +26.7%
- S&P 500, same days
- +8.6%
Measured over 30 trading days, to the Aug 19 close.
Traded Wed, Jul 6. Filed Fri, Jul 8, 1:51 PM ET, during the session. Returns use the Jul 8 close and the Aug 19 close. Not investment advice.